Loading…
Polyphenolic Compounds from Lespedeza bicolor Protect Neuronal Cells from Oxidative Stress
Pterocarpans and related polyphenolics are known as promising neuroprotective agents. We used models of rotenone-, paraquat-, and 6-hydroxydopamine-induced neurotoxicity to study the neuroprotective activity of polyphenolic compounds from and their effects on mitochondrial membrane potential. We iso...
Saved in:
Published in: | Antioxidants 2022-04, Vol.11 (4), p.709 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Pterocarpans and related polyphenolics are known as promising neuroprotective agents. We used models of rotenone-, paraquat-, and 6-hydroxydopamine-induced neurotoxicity to study the neuroprotective activity of polyphenolic compounds from
and their effects on mitochondrial membrane potential. We isolated 11 polyphenolic compounds: a novel coumestan lespebicoumestan A (
) and a novel stilbenoid 5'-isoprenylbicoloketon (
) as well as three previously known pterocarpans, two pterocarpens, one coumestan, one stilbenoid, and a dimeric flavonoid. Pterocarpans
and
, stilbenoid
, and dimeric flavonoid
significantly increased the percentage of living cells after treatment with paraquat (PQ), but only pterocarpan
slightly decreased the ROS level in PQ-treated cells. Pterocarpan
and stilbenoid
were shown to effectively increase mitochondrial membrane potential in PQ-treated cells. We showed that pterocarpans
and
, containing a 3'-methyl-3'-isohexenylpyran ring; pterocarpens
and
, with a double bond between C-6a and C-11a; and coumestan
significantly increased the percentage of living cells by decreasing ROS levels in 6-OHDA-treated cells, which is in accordance with their rather high activity in DPPH
and FRAP tests. Compounds
and
effectively increased the percentage of living cells after treatment with rotenone but did not significantly decrease ROS levels. |
---|---|
ISSN: | 2076-3921 2076-3921 |
DOI: | 10.3390/antiox11040709 |